Global Metabotropic Glutamate Receptor 5 Market By Product Type (Alloswitch-1, BMS-952048) And By End-Users/Application (Major Depressive Disorder, Alcohol Assiction) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Metabotropic Glutamate Receptor 5 market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Metabotropic Glutamate Receptor 5 market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Metabotropic Glutamate Receptor 5 industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Metabotropic Glutamate Receptor 5 ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Metabotropic Glutamate Receptor 5 market.

The following manufacturers are covered in this report:
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bristol-Myers Squibb Company
  • Eisai Co Ltd
  • Eli Lilly and Company
  • Heptares Therapeutics Ltd
  • Johnson & Johnson
  • Merz Pharma GmbH & Co KgaA
  • Novartis AG
  • Richter Gedeon Nyrt
  • Sumitomo Dainippon Pharma Co Ltd
  • Toray Industries Inc

The report estimates on the Metabotropic Glutamate Receptor 5 market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Metabotropic Glutamate Receptor 5 market report consist of all leading industry players, Metabotropic Glutamate Receptor 5 business sections, company profile, revenue supply by Metabotropic Glutamate Receptor 5 industry sections, global Metabotropic Glutamate Receptor 5 market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Metabotropic Glutamate Receptor 5 market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Metabotropic Glutamate Receptor 5 market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Metabotropic Glutamate Receptor 5 market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Metabotropic Glutamate Receptor 5 market.

Report Opportunity: Global Metabotropic Glutamate Receptor 5 Market

This report delivers an analytical examination of the Metabotropic Glutamate Receptor 5 market summarized in broad sections such as
  1. Metabotropic Glutamate Receptor 5 Market Summary
  2. Key Commercial Growths in the Metabotropic Glutamate Receptor 5 Industry
  3. Market Dynamics Affecting the Metabotropic Glutamate Receptor 5 Industry
  4. Important Market Trends and Future Development Scenario of the Metabotropic Glutamate Receptor 5 Market
  5. Metabotropic Glutamate Receptor 5 Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Metabotropic Glutamate Receptor 5 Industry
  7. Positioning of Main Market Players in the Metabotropic Glutamate Receptor 5 Industry
  8. Metabotropic Glutamate Receptor 5 Market Revenue and Forecast, by Application, 2018 - 2028
  9. Metabotropic Glutamate Receptor 5 Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Metabotropic Glutamate Receptor 5 Market Revenue and Forecast, by Geography, 2018 - 2028
Metabotropic Glutamate Receptor 5 Market Segmentation:

The report provides detailed examination of the Metabotropic Glutamate Receptor 5 market on the basis of various segments such as type, application and end-use industry. The Metabotropic Glutamate Receptor 5 market is segmented as follows:

Metabotropic Glutamate Receptor 5 Market, by Type:
  • Alloswitch-1
  • BMS-952048
  • BMS-955829
  • Dipraglurant ER
  • Others
Metabotropic Glutamate Receptor 5 Market, by Application:
  • Major Depressive Disorder
  • Alcohol Assiction
  • Alzheimer\'s Disease
  • Others
Geographic Coverage

The report on the Metabotropic Glutamate Receptor 5 market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Metabotropic Glutamate Receptor 5 Market Revenue and Forecast
  • U.S.
  • Canada
Europe Metabotropic Glutamate Receptor 5 Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Metabotropic Glutamate Receptor 5 Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Metabotropic Glutamate Receptor 5 Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Metabotropic Glutamate Receptor 5 Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Metabotropic Glutamate Receptor 5 Market Snapshot
          2.1.1. Global Metabotropic Glutamate Receptor 5 Market By Type,2019
               2.1.1.1.Alloswitch-1
               2.1.1.2.BMS-952048
               2.1.1.3.BMS-955829
               2.1.1.4.Dipraglurant ER
               2.1.1.5.Others
          2.1.2. Global Metabotropic Glutamate Receptor 5 Market By Application,2019
               2.1.2.1.Major Depressive Disorder
               2.1.2.2.Alcohol Assiction
               2.1.2.3.Alzheimer\'s Disease
               2.1.2.4.Others
          2.1.3. Global Metabotropic Glutamate Receptor 5 Market By End-use,2019
          2.1.4. Global Metabotropic Glutamate Receptor 5 Market By Geography,2019

3. Global Metabotropic Glutamate Receptor 5 Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028

5. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028

6. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028

7. Global Metabotropic Glutamate Receptor 5 Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Metabotropic Glutamate Receptor 5 Market Analysis, 2018 – 2028 
          7.2.1. North America Metabotropic Glutamate Receptor 5 Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Metabotropic Glutamate Receptor 5 Market Analysis, 2018 – 2028 
          7.3.1.  Europe Metabotropic Glutamate Receptor 5 Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Metabotropic Glutamate Receptor 5 Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Metabotropic Glutamate Receptor 5 Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Metabotropic Glutamate Receptor 5 Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Metabotropic Glutamate Receptor 5 Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Metabotropic Glutamate Receptor 5 Market Analysis, 2018 – 2028 
          7.6.1.  MEA Metabotropic Glutamate Receptor 5 Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Metabotropic Glutamate Receptor 5 Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Metabotropic Glutamate Receptor 5 Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Metabotropic Glutamate Receptor 5 Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Metabotropic Glutamate Receptor 5 Providers
        8.4.1 Addex Therapeutics Ltd
                8.1.1 Business Description
                8.1.2 Addex Therapeutics Ltd Geographic Operations
                8.1.3 Addex Therapeutics Ltd Financial Information
                8.1.4 Addex Therapeutics Ltd Product Positions/Portfolio
                8.1.5 Addex Therapeutics Ltd Key Developments
        8.4.2 Aevi Genomic Medicine Inc
                8.2.1 Business Description
                8.2.2 Aevi Genomic Medicine Inc Geographic Operations
                8.2.3 Aevi Genomic Medicine Inc Financial Information
                8.2.4 Aevi Genomic Medicine Inc Product Positions/Portfolio
                8.2.5 Aevi Genomic Medicine Inc Key Developments
        8.4.3 Bristol-Myers Squibb Company
                8.3.1 Business Description
                8.3.2 Bristol-Myers Squibb Company Geographic Operations
                8.3.3 Bristol-Myers Squibb Company Financial Information
                8.3.4 Bristol-Myers Squibb Company Product Positions/Portfolio
                8.3.5 Bristol-Myers Squibb Company Key Developments
        8.4.4 Eisai Co Ltd
                8.4.1 Business Description
                8.4.2 Eisai Co Ltd Geographic Operations
                8.4.3 Eisai Co Ltd Financial Information
                8.4.4 Eisai Co Ltd Product Positions/Portfolio
                8.4.5 Eisai Co Ltd Key Developments
        8.4.5 Eli Lilly and Company
                8.5.1 Business Description
                8.5.2 Eli Lilly and Company Geographic Operations
                8.5.3 Eli Lilly and Company Financial Information
                8.5.4 Eli Lilly and Company Product Positions/Portfolio
                8.5.5 Eli Lilly and Company Key Developments
        8.4.6 Heptares Therapeutics Ltd
                8.6.1 Business Description
                8.6.2 Heptares Therapeutics Ltd Geographic Operations
                8.6.3 Heptares Therapeutics Ltd Financial Information
                8.6.4 Heptares Therapeutics Ltd Product Positions/Portfolio
                8.6.5 Heptares Therapeutics Ltd Key Developments
        8.4.7 Johnson & Johnson
                8.7.1 Business Description
                8.7.2 Johnson & Johnson Geographic Operations
                8.7.3 Johnson & Johnson Financial Information
                8.7.4 Johnson & Johnson Product Positions/Portfolio
                8.7.5 Johnson & Johnson Key Developments
        8.4.8 Merz Pharma GmbH & Co KgaA
                8.8.1 Business Description
                8.8.2 Merz Pharma GmbH & Co KgaA Geographic Operations
                8.8.3 Merz Pharma GmbH & Co KgaA Financial Information
                8.8.4 Merz Pharma GmbH & Co KgaA Product Positions/Portfolio
                8.8.5 Merz Pharma GmbH & Co KgaA Key Developments
        8.4.9 Novartis AG
                8.9.1 Business Description
                8.9.2 Novartis AG Geographic Operations
                8.9.3 Novartis AG Financial Information
                8.9.4 Novartis AG Product Positions/Portfolio
                8.9.5 Novartis AG Key Developments
        8.4.10 Richter Gedeon Nyrt
                8.10.1 Business Description
                8.10.2 Richter Gedeon Nyrt Geographic Operations
                8.10.3 Richter Gedeon Nyrt Financial Information
                8.10.4 Richter Gedeon Nyrt Product Positions/Portfolio
                8.10.5 Richter Gedeon Nyrt Key Developments
        8.4.11 Sumitomo Dainippon Pharma Co Ltd
                8.11.1 Business Description
                8.11.2 Sumitomo Dainippon Pharma Co Ltd Geographic Operations
                8.11.3 Sumitomo Dainippon Pharma Co Ltd Financial Information
                8.11.4 Sumitomo Dainippon Pharma Co Ltd Product Positions/Portfolio
                8.11.5 Sumitomo Dainippon Pharma Co Ltd Key Developments
        8.4.12 Toray Industries Inc
                8.12.1 Business Description
                8.12.2 Toray Industries Inc Geographic Operations
                8.12.3 Toray Industries Inc Financial Information
                8.12.4 Toray Industries Inc Product Positions/Portfolio
                8.12.5 Toray Industries Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Metabotropic Glutamate Receptor 5 Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Metabotropic Glutamate Receptor 5 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Metabotropic Glutamate Receptor 5 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Metabotropic Glutamate Receptor 5 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Metabotropic Glutamate Receptor 5 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Metabotropic Glutamate Receptor 5 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Metabotropic Glutamate Receptor 5 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Metabotropic Glutamate Receptor 5 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Metabotropic Glutamate Receptor 5 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Metabotropic Glutamate Receptor 5 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Metabotropic Glutamate Receptor 5 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Metabotropic Glutamate Receptor 5 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Metabotropic Glutamate Receptor 5 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Metabotropic Glutamate Receptor 5 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Metabotropic Glutamate Receptor 5 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Metabotropic Glutamate Receptor 5 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Metabotropic Glutamate Receptor 5: Market Segmentation 
FIG. 2 Global Metabotropic Glutamate Receptor 5 Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Metabotropic Glutamate Receptor 5 Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Metabotropic Glutamate Receptor 5 Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Metabotropic Glutamate Receptor 5 Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Metabotropic Glutamate Receptor 5 Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Metabotropic Glutamate Receptor 5 Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Metabotropic Glutamate Receptor 5 Providers, 2019
FIG. 11 Global Metabotropic Glutamate Receptor 5 Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Metabotropic Glutamate Receptor 5 Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Metabotropic Glutamate Receptor 5 Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Metabotropic Glutamate Receptor 5 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Metabotropic Glutamate Receptor 5 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Metabotropic Glutamate Receptor 5 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Metabotropic Glutamate Receptor 5 Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Metabotropic Glutamate Receptor 5 Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Metabotropic Glutamate Receptor 5 market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
7260

2587

OUR CLIENT